A promoter polymorphism -2122C>T of CHI3L1 is associated with serum low density lipoprotein cholesterol level in Korean subjects

Clinical Biochemistry

Volumn 43, Issue 15, 2010, Pages 1195-1200

  Lee, Haeyong ^a   Kang, Ryunhwa ^a   Jee, Sun Ha ^b   Yoon, Yoosik ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

CHI3L1; EMSA; LDL cholesterol; Promoter; Rs946261; SNP

Indexed keywords

GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NUCLEAR FACTOR; PROTEIN CHITINASE 3 LIKE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; KOREA; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE PAIRING; CHOLESTEROL, LDL; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GLYCOPROTEINS; HUMANS; LECTINS; MALE; METABOLOME; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPUBLIC OF KOREA; RNA, MESSENGER;

EID: 77956721003     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.07.017     Document Type: Article

References (28)

1. Beekman M., Heijmans B.T., Martin N.G., Pedersen N.L., Whitfield J.B., DeFaire U., et al. Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res 2002, 5:87-97.
2. Hemminki K., Lorenzo Bermejo J., Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 2006, 7:958-965.
3. Rader D.J., Cohen J., Hobbs H.H. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 2003, 111:1795-1803.
4. Cambien F., Tiret L. Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation 2007, 116:1714-1724.
5. Sandhu M.S., Waterworth D.M., Debenham S.L., Wheeler E., Papadakis K., Zhao J.H., et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008, 371:483-491.
6. Rehli M., Krause S.W., Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 1997, 43:221-225.
7. Kawada M., Hachiya Y., Arihiro A., Mizoguchi E. Role of mammalian chitinases in inflammatory conditions. Keio J Med 2007, 56:21-27.
8. Coffman F.D. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci 2008, 45:531-562.
9. Lee C.G., Hartl D., Lee G.R., Koller B., Matsuura H., Da Silva C.A., et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med 2009, 206:1149-1166.
10. Ober C., Chupp G.L. The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr Opin Allergy Clin Immunol 2009, 9:401-408.
11. Berres M.L., Papen S., Pauels K., Schmitz P., Zaldivar M.M., Hellerbrand C., et al. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol 2009, 50:370-376.
12. Rathcke C.N., Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006, 55:221-227.
13. Kucur M., Isman F.K., Karadag B., Vural V.A., Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007, 18:391-396.
14. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
15. Cha M.H., Kim I.C., Kim K.S., Kang B.K., Choi S.M., Yoon Y. Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women. Metabolism 2007, 56:806-813.
16. Bertram C., Misso N.L., Fogel-Petrovic M., Figueroa C., Thompson P.J., Bhoola K.D. Comparison of kinin B(1) and B(2) receptor expression in neutrophils of asthmatic and non-asthmatic subjects. Int Immunopharmacol 2007, 7:1862-1868.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
18. Bland J.M., Altman D.G. Multiple significance tests: the Bonferroni method. Bmj 1995, 310:170.
19. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37:1217-1223.
20. Zhao X., Tang R., Gao B., Shi Y., Zhou J., Guo S., et al. Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 2007, 80:12-18.
21. Natarajan S., Glick H., Criqui M., Horowitz D., Lipsitz S.R., Kinosian B. Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 2003, 25:50-57.
22. Rathcke C.N., Vestergaard H. YKL-40 an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009, 8:61.
23. Boot R.G., van Achterberg T.A., van Aken B.E., Renkema G.H., Jacobs M.J., Aerts J.M., et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999, 19:687-694.
24. Fach E.M., Garulacan L.A., Gao J., Xiao Q., Storm S.M., Dubaquie Y.P., et al. In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics 2004, 3:1200-1210.
25. Nishikawa K.C., Millis A.J. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 2003, 287:79-87.
26. Hempen M., Kopp H.P., Elhenicky M., Hobaus C., Brix J.M., Koppensteiner R., et al. YKL-40 is elevated in morbidly obese patients and declines after weight loss. Obes Surg 2009, 19:1557-1563.
27. Wang Y., Ripa R.S., Johansen J.S., Gabrielsen A., Steinbruchel D.A., Friis T., et al. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J 2008, 42:295-302.
28. Kel A.E., Gossling E., Reuter I., Cheremushkin E., Kel-Margoulis O.V., Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003, 31:3576-3579.